Registration - Welcome
Chairs: O. Ζoras, J. Duran Moreno, N. Memos
10.00-10.30 Gist: A proof on concept tumor with 10 relevant questions in 2021 A. Le Cesne
10.30-11.00 Surgery for GIST primary tumors: new laparoscopic techniques and results of neoadjuvant therapy P. Hohenberger
11.00-11.30 Desmoid tumors: modern surgical approach E. De Bree
Chairs: S. Kokkali, T. Kormas, K. Diamantopoulou
11.30-12.00 Pathology of Ewing sarcomas E. Skarpidi
12.00-12.30 Systemic treatment of Ewing sarcomas V. Papadakis
12.30-13.00 Surgical approach of Ewing sarcomas I. Papanastasiou
13.30-13.30 Interventional radiology techniques for sarcoma metastatic disease D. Filippiadis
Lunch - collaborations table
Chairs: V. Zolota, V. Ramfidis
14.30-15.00 Pathology of EHE P. Korkolopoulou
15.00-15.30 Update on EHE treatment S. Stacchiotti
Chairs: D. Herceg, M. Bobos
15.30-16.00 Surgical approach of cutaneous sarcomas N. Memos
16.00-16.30 Cutaneous sarcomas systemic treatment J. Duran Moreno
16.30-17.00 Small tumors, big consequences: An Update on Superficial Sarcomas K. Linos
Coffee Break
Chairs: D.J. Papachristou, I. Boukovinas, P. Papaggelopoulos
17.30-18.00 The New WHO classification of STT: evolving concepts and standing issues A.P. Dei Tos
18.00-18.30 Biomarkers to select patients for adjuvant treatment in localized soft tissue sarcoma K. Boye
18.30-19.00 Challenges in histopathological evaluation and grading of soft tissue sarcoma after preoperative oncological treatment I. Lobmaier
19.00-19.30 Immunotherapy of sarcomas J. Yves Blay
19.30-20.00 Soft Tissue Sarcomas of the Extremities: Principles of Surgical Treatment and Isolated Limb Perfusion Ν. Vassos
20.00-20.30 NAPAGE: results of a phase I/II trial A. Digklia
Dinner
Chairs: I. Athanasiadis, A. Psyrri, A. Stergioula
09.00-09.30 Current insights in diagnosis and classification of retroperitoneal sarcomas G. Agrogiannis
09.30-10.00 Treatment strategy of retroperitoneal sarcoma D. Tzanis
10.00-10.30 Radiotherapy in soft tissue sarcomas J. Nixon
10.30-11.00 Update on conventional and experimental treatment options for adipocytic sarcomas P. Schöffski
11.00-11.30 An update on angiosarcoma R. Jones
Coffee Break
Chairs: K. Boye, K. Malizos
12.00-12.30 Old school histology meets complex karyotype: an update on osteosarcomas D.J. Papachristou
12.30-13.00 Imaging of osteosarcomas M. Tzalonikou
13.00-13.30 Surgical approach of Osteosarcomas V. Kontogeorgakos
13.30-14.00 Novel therapies of bone tumors E. Palmerini
Chairs: E. Dimitriadis, A. Kyriazoglou
15.00-15.30 Sarcoma research from the lab to the clinic: hypes, hopes and successes C. Serrano
15.30-16.00 Potential molecular biomarkers of response to eribulin in patients withleiomyosarcoma A. Wozniak
16.00-16.30 Molecular characterization and clinical implication of soft tissue sarcomas: a greek sarcoma project S. Kokkali
16.30-17.00 NGS analysis for diagnostic, prognostic, and predictive biomarkers in sarcomas E. Papadopoulou
Coffee Break
Chairs: V. Georgoulias, G. Agrogiannis
17.30-18.00 Systemic treatment based on histopathology S. Gennatas
18.00-18.30 Treatment based on molecular genetics A. Constantinidou
Chairs: D.J. Papachristou, A. Stergioula, N. Memos
18.30-19.00 Optimizing the use of trabectedin in the daily clinical practice in STS A. Kyriazoglou
Sponsored by Genesis
19.00-19.30 Quality of life in sarcoma patients O. Husson
19.30-20.00 Need for a new collaborative action in sarcoma care access I. Boukovinas
Conclusions